CJC-1295 With DAC vs Without DAC: Half-Life Changes Everything

Without DAC: CJC-1295 has a half-life of approximately 30 minutes. When injected, it produces a sharp GH pulse by stimulating pituitary somatotrophs -- the peptide activates GHRH receptors, GH is released, and the peptide clears before the next injection. This sharp, transient signal closely mimics the way natural GHRH triggers pulsatile GH secretion throughout the day.

With DAC: the maleimide linkage in the Drug Affinity Complex allows CJC-1295 to covalently bind albumin in the bloodstream. Albumin's long circulation half-life (approximately 19 days) acts as a carrier, extending CJC-1295's effective half-life to 6-8 days. The result is continuously elevated GHRH signaling -- not a pulse, but a sustained plateau. This creates a blunted but persistent GH and IGF-1 elevation that does not mimic natural pulsatile physiology.

The CJC-1295 No DAC + Ipamorelin combination works through complementary pulsatile mechanisms. CJC-1295 No DAC activates GHRH receptors, triggering GH release from the pituitary. Ipamorelin activates ghrelin receptors (GHSR-1a) simultaneously, amplifying the same GH pulse through a different receptor system. Together, they produce a GH pulse substantially larger than either agent alone.

The standard No DAC + Ipamorelin dose is 100mcg of each, 2-3 times daily, typically dosed before bed (primary) and optionally upon waking and/or pre-workout. Timing on an empty stomach improves GH pulse amplitude.

Choose CJC-1295 No DAC when: running anti-aging protocols emphasizing physiological GH pulsatility, optimizing body composition with the ipamorelin stack, improving sleep quality through the nocturnal GH pulse, or when stacking with any GHRP (ipamorelin, GHRP-2, hexarelin). This is the more physiologically aligned option and represents the majority of active research protocols.

Choose CJC-1295 with DAC when: protocol convenience is the primary constraint, daily injections are not feasible, and simplified once or twice weekly dosing is a priority. The with-DAC version still elevates IGF-1 and provides GH axis stimulation -- it just does so through a continuous rather than pulsatile mechanism.